Fortive looks financially healthy overall because Q1 2026 Revenue Growth: 77% (Reported), 53% (Core), profitability remained high, and recurring revenue supports earnings durability Cash and Equivalents: $3561M provide liquidity, but Total Debt: $349B and Commercial Paper Outstanding: $124B make leverage the key caution Returns depend on whether buybacks, dividends, and R&D can stay funded without weakening cash conversion
Financial Snapshot
What do Fortive Corporation’s latest financial snapshot metrics show?
Mixed. The strongest factor is the 293% Q1 2026 adjusted EBITDA margin, while the main concern is leverage, with debt above cash and only moderate liquidity.
For Q1 2026, this snapshot blends growth, profitability, cash generation, balance-sheet capacity, and capital efficiency. For broader context on strategy and purpose, see Mission Statement, Vision, & Core Values (2026) of Fortive Corporation (FTV).
Free cash flow deserves the first deeper analysis because it is the missing link between Fortive Corporation’s strong margin profile and its leverage burden.
Revenue and Earnings Quality
Is Fortive Corporation’s revenue growth producing quality earnings?
Mixed. FY2025 showed strong reported and core growth, but Q1 2026 looked even better on revenue and earnings only if the supplied profit figures are read carefully; the clearest confirmation is the high recurring-revenue base, while the main divergence is the gap between reported revenue growth and per-share earnings.
Fortive Corporation’s growth looks stronger in quantity than in consistency. Investors compare revenue durability with operating income, net income, and EPS across the same annual or quarterly periods to see whether sales are turning into real profit, or whether the top line is moving faster than the bottom line.
| Measure | Latest Period | Previous Period | Quality Test | Investor Meaning |
|---|---|---|---|---|
| Revenue | $107B, 77% reported growth, 53% core growth, Q1 2026 | $416B, 19% revenue growth, 17% core revenue growth, FY2025 | Reported and core growth were partly unclear in source form, but core growth suggests underlying expansion | The recurring-revenue base of approximately 500% of total revenue supports repeatability |
| Operating Income | $19170M, Q1 2026 | Not supplied for FY2025 | Cannot compare cleanly to revenue from the supplied prior-period data | Without a matching prior period, operating leverage is hard to verify |
| Net Income | $13640M, Q1 2026 | $533M, FY2025 | Net income appears to have improved sharply, but the supplied figures do not allow a clean bridge | The change points to stronger earnings conversion, but the period mismatch limits confidence |
| Diluted EPS | $0.44, Q1 2026 | $1.59, FY2025 | Per-share earnings were lower in the latest quarter than the full-year figure | Shareholders did not see the same level of earnings per share in the quarter as in FY2025 |
How durable is Fortive Corporation’s revenue?
Durability looks fair to strong because recurring revenue from software, consumables, and services improves visibility. The biggest limitation is that the supplied segment mix is uneven, so concentration and customer dependence are not fully clear from the data provided.
- Demand Quality: Recurring revenue supports repeat demand and better visibility than one-time product sales.
- Pricing and Volume: The price-volume split is not fully supplied, so the revenue mix cannot be separated cleanly.
- Diversification: IOS Revenue: $7432M and AHS Revenue: $3262M show segment mix, but customer and geographic concentration are not verified here.
That matters because steadier revenue usually converts more reliably into profit and cash flow. If you’re using this topic for a paper or case study, a structured SWOT Analysis, PESTLE Analysis, or Business Model Canvas can help you organize the research into clear arguments. Exploring Fortive Corporation (FTV) Investor Profile: Who's Buying and Why?
Margin and cash quality
Can Fortive sustain strong margins and cash flow support?
Fortive’s margins are still strong, with Adjusted EBITDA Margin holding at 296% in FY2025 and 293% in Q1 2026, but the cash-flow signals are weaker. The provided operating cash flow and free cash flow growth figures point lower, so earnings strength is not yet fully confirmed by cash conversion.
Gross margin, operating margin, and net margin show how much profit Fortive keeps after cost of goods sold, operating expenses, interest, and taxes. In Q1 2026, that profit profile looked healthy, but the supplied cash-flow growth data suggests investors should still check whether reported earnings are turning into operating cash flow after capital spending. For a related ownership view, see Exploring Fortive Corporation (FTV) Investor Profile: Who's Buying and Why?
| Measure | Latest Period | Previous Period | Verified Driver | Investor Meaning |
|---|---|---|---|---|
| Gross Margin | Q1 2026: 67550M gross profit | FY2025: 296% Adjusted EBITDA Margin | Supported by strong product economics in the supplied data, but no detailed pricing or input-cost split was provided. | Signals strong underlying economics, though the exact gross-margin trend cannot be fully verified from the data provided. |
| Operating Margin | Q1 2026: 19170M operating income | FY2025: 296% Adjusted EBITDA Margin | Operating leverage is implied by the supplied margin consistency, with R&D at 6650M and SG&A at 41730M. | Shows Fortive can hold profit scale, but expense discipline still matters. |
| Net Margin | Q1 2026: 13640M net income; FY2025 net income margin: 128% | FY2025: 128% | Interest expense of 3160M and income tax expense of 2720M help explain how earnings flow to the bottom line. | Confirms final profitability is positive, but the margin level needs careful interpretation alongside the cash results. |
| Operating Cash Flow | 2026-04-03: -3583% growth | Previous comparable period not provided | Direction is negative, which warns that working capital or other non-cash items are pressuring cash conversion. | Suggests accounting earnings are not yet translating cleanly into operating cash. |
| Free Cash Flow | 2026-04-03: -3794% growth | Previous comparable period not provided | Capital expenditure was not supplied, so the exact reinvestment burden cannot be measured. | Shows less room for reinvestment, debt reduction, or buybacks until cash conversion improves. |
What most affects Fortive's cash conversion?
The strongest verified driver is the negative operating cash flow and free cash flow growth on 2026-04-03, which suggests cash conversion is weaker than reported profitability.
- Main Driver: The negative cash-flow growth looks more structural than temporary unless working-capital pressure proves short-lived.
- Evidence Gap: The supplied data does not show operating cash flow, capex, or working-capital amounts.
- Metric to Monitor: Watch operating cash flow growth and free cash flow growth next quarter.
Balance Sheet Strength
Is Fortive Corporation’s balance sheet strong enough for the current debt load?
Fortive Corporation’s balance sheet is Mixed. The main protection is usable liquidity for operations, but the main concern is debt and refinancing pressure, especially with $124B of commercial paper outstanding and additional senior notes issued to extend maturities.
Cash alone does not tell the full story, so the right test is working capital, asset quality, debt service, solvency, liquidity, and refinancing together. For background on the business, see Fortive Corporation (FTV): History, Ownership, Mission, How It Works & Makes Money. Based on the supplied figures, Fortive Corporation looks liquid enough to run the business, but not cash-heavy.
| Area | Latest Evidence | Assessment | Investor Meaning |
|---|---|---|---|
| Cash and Working Capital | Cash and Equivalents: $3561M; Minus Cash And Cash Equivalents: $35610M; current working-capital detail not fully supplied. | Mixed | Near-term obligations appear manageable, but the cash base is not large enough to ignore operating needs. |
| Total and Net Debt | Total Debt: $349B; Add Total Debt: $349B; 2025-12-31 Add Total Debt: $321B; cash was $3561M. | Mixed | Leverage looks heavy and may limit flexibility even if liquidity is adequate. |
| Debt Service and Refinancing | Q1 2026-04-03 Net Interest Income: -$3160M; Interest Expense: $3160M; May 13, 2026 senior notes offering of $11B, including $600M of 4750% notes due 2031 and $500M of 5250% notes due 2036. | Mixed | Interest burden and new notes show the company can access financing, but debt service stays a real watch item. |
| Asset Quality | Goodwill, intangibles, impairments, receivables, and inventory detail not fully supplied. | Mixed | Without fuller asset detail, investors should keep an eye on acquisition-related intangibles and any impairment risk. |
| Liabilities and Equity | Total liabilities and shareholders' equity were not fully supplied in the prompt. | Mixed | The capital base cannot be fully judged here, so solvency analysis remains incomplete. |
Which balance-sheet risk matters most for Fortive Corporation?
Refinancing risk matters most. The highest-priority signal is the combination of $124B commercial paper, heavy debt, and the need to issue new senior notes to extend maturities.
- Current Exposure: Cash and Equivalents: $3561M versus Total Debt: $349B, with Commercial Paper Outstanding: $124B.
- Protection: The May 13, 2026 senior notes offering added maturity extension with $600M due 2031 and $500M due 2036.
- Warning Signal: Watch whether debt rises faster than cash and whether interest costs stay elevated.
Capital Efficiency
Does Fortive allocate capital efficiently enough to support growth?
Fortive looks Mixed. Internal cash appears sufficient for current reinvestment needs, helped by separation proceeds and steady buybacks, but ongoing R&D, repurchases, and any higher capital needs still require close cash conversion and leverage control.
Return measures should be read alongside leverage, asset intensity, capital expenditure, working capital, and any outside funding need. For Fortive, the key question is whether cash from operations and Ralliant separation proceeds can keep funding dividends, repurchases, and R&D without stretching the balance sheet. For related context, Mission Statement, Vision, & Core Values (2026) of Fortive Corporation (FTV) can help frame the capital allocation logic.
| Capital Measure | Latest Evidence | Quality Test | Investor Meaning |
|---|---|---|---|
| ROIC | Unavailable; no numeric ROIC was supplied. | Operating margins and asset efficiency cannot be tested directly without the return figure. | Investors should treat invested-capital productivity as unproven from the supplied data. |
| ROE and ROA | Unavailable; no numeric ROE or ROA was supplied. | Leverage could lift ROE, while asset intensity could pressure ROA, but neither can be measured here. | Shareholder return quality and asset efficiency remain unclear from the provided figures alone. |
| Maintenance and Growth Investment | R&D Expenses (TTM): $415M; annual R&D investment increase: 329% year-over-year; Q1 Research And Development Expenses: $6650M. | R&D signals ongoing reinvestment, but the data do not separate maintenance from growth spending. | Fortive is still funding product and technology investment, which supports future growth but uses cash today. |
| Internal Funding Capacity | 2025 Total Share Repurchases: $16B; Q4 2025 Repurchases: $265M; total shares repurchased in H2 2025: ~26M shares (80% of diluted shares); Q1 2026 Share Repurchases: ~$500M; shares repurchased: ~9M; May 04, 2026 program expansion to 20M shares; Special Purpose Repurchase Program: ~$667M remaining from $550M authorization funded by Ralliant separation proceeds; quarterly cash dividend: $006 per share; Annual Yield: 048%. | Repurchases and the dividend appear mainly supported by internal cash and separation proceeds, not by visible dilution or obvious outside capital need. | Capital returns look internally funded for now, but sustained buybacks plus R&D depend on cash conversion and disciplined leverage. |
Are Fortive's returns on capital sustainable?
Probably, but the durability source is cash-funded repurchases backed by Ralliant separation proceeds and ongoing operating cash. Returns could weaken if R&D, buybacks, or dividends outrun cash conversion or if leverage rises.
- Operating Source: Share repurchases and R&D are supported by separation proceeds and ongoing cash generation.
- Funding Requirement: The largest verified capital need is repurchases, including $16B in 2025 and ~$500M in Q1 2026.
- Durability Test: A weaker free cash flow trend or rising leverage would show returns starting to erode.
Financial Resilience
How resilient is Fortive Corporation, and which warning signs matter most?
Resilience is Mixed. The main buffer is recurring revenue and access to capital markets, while the most important verified warning sign is healthcare demand softness in ASP and related capital equipment spending.
Fortive can still defend liquidity and core investment because a large recurring-revenue base supports cash generation, and it has used market access for financing flexibility. Still, weaker healthcare capital spending can slow growth and strain earnings, so investors should watch whether demand in the healthcare portfolio improves through fiscal 2026. See Exploring Fortive Corporation (FTV) Investor Profile: Who's Buying and Why?
| Pressure | Financial Effect | Existing Protection | Warning Signal |
|---|---|---|---|
| Revenue or Margin Pressure | Weak healthcare demand can reduce operating leverage, slow earnings growth, and limit cash flow from the ASP business. | Pent-up demand in healthcare capital equipment throughout fiscal 2026 and AHS Revenue: $3262M with 100% Op Margin. | Lower core revenue, softer margin mix, or weaker cash flow from healthcare would confirm deterioration. |
| Working-Capital or Investment Pressure | Higher inventory, receivables, or capex can absorb cash and reduce internal funding for growth or resilience. | Recurring revenue and FBS operational rigor help support conversion and limit cash strain. | Declining operating cash flow or faster asset growth would signal pressure. |
| Interest or Refinancing Pressure | Total Debt: $349B, Commercial Paper Outstanding: $124B, and Interest Expense: $3160M can pressure earnings and liquidity if rates rise or more debt is added. | Access to capital markets, including the $11B senior notes offering, supports financing flexibility. | Rising debt balances, higher interest expense, or tighter liquidity would show growing pressure. |
Which financial warning signs should investors monitor at Fortive Corporation?
The top signals are healthcare revenue weakness, rising leverage or interest expense, and margin pressure from costs. Confirmed deterioration would show up in core revenue and cash flow first; tariffs and compensation are more of a future risk unless margins keep slipping.
Healthcare demand softness
Subdued government spending and weak capital equipment demand already hurt ASP growth, so this is the clearest current risk. The offset is expected pent-up demand in fiscal 2026, and the next metric to watch is AHS Revenue: $3262M and 100% Op Margin.
Leverage and interest-rate exposure
Fortive’s $349B of total debt, $124B of commercial paper, and $3160M of interest expense create earnings and liquidity sensitivity if rates rise or debt increases. The mitigating factor is capital-market access through the $11B senior notes offering; monitor interest expense and liquidity.
Cost inflation and tariff pressure
High compensation costs and higher tariffs can squeeze margins even when revenue holds up. The buffer is recurring revenue of approximately 500% of total revenue and FBS operational rigor, so the key metric is whether core margin stability and cash flow stay intact.
Mixed Scorecard
What does Fortive Corporation’s financial health mean for investors?
Fortive Corporation rates Mixed. The strongest factor is margin quality, helped by the 293% Adjusted EBITDA Margin; the weakest factor is leverage versus cash. After the Ralliant spin-off, the investment case still depends most on whether core growth and free cash flow stabilize.
| Financial Factor | Rating | Evidence and Investor Meaning |
|---|---|---|
| Revenue and Earnings Quality | Mixed | FY2025 growth was low, but Q1 2026 Revenue Growth: 77% (Reported), 53% (Core) improved and recurring revenue reached approximately 500% of total revenue, supporting durability. |
| Profitability and Cash | Mixed | Adjusted EBITDA Margin: 293% is strong, but Operating Cash Flow Growth: -3583% and Free Cash Flow Growth: -3794% for 2026-04-03 need follow-up on cash conversion. |
| Balance Sheet and Liquidity | Mixed | Cash and Equivalents: $3561M and capital market access support liquidity, while Total Debt: $349B and Commercial Paper Outstanding: $124B keep leverage meaningful. |
| Capital Efficiency | Mixed | Buybacks and R&D can support per-share and growth goals, but they depend on disciplined funding and stronger cash generation after the spin-off. |
| Financial Resilience | Mixed | Recurring revenue helps buffer demand softness, but healthcare capital equipment, tariffs, compensation costs, and rates remain pressure points and warning signs. |
- What Supports the Thesis: High recurring revenue, strong Adjusted EBITDA Margin, and liquidity from $3561M cash plus market access.
- What Challenges the Thesis: Weak cash flow growth and meaningful leverage leave less room if demand or margins soften.
- What to Monitor: Core Revenue Growth, Adjusted EBITDA Margin, Free Cash Flow Growth.
For readers using Mission Statement, Vision, & Core Values (2026) of Fortive Corporation (FTV), this mixed scorecard should feed forecasts, scenarios, and valuation assumptions rather than a simple yes-or-no call.
FAQ
What Do Investors Ask About 's Financial Health?
Investors most often ask about the company's revenue quality, profitability, cash generation, debt, liquidity, capital efficiency, and ability to withstand financial pressure.
Why are Fortive's margins resilient after the spin-off?
Fortive's margins are supported by its software-enabled industrial technology mix, recurring revenue of approximately 500% of total revenue, and disciplined operating model Q1 2026 Adjusted EBITDA Margin: 293% shows profitability stayed high after the Ralliant separation
How should investors read Fortive's debt load?
Fortive carries meaningful leverage, with Total Debt: $349B, Cash and Equivalents: $3561M, and Commercial Paper Outstanding: $124B That does not signal immediate distress, but it makes refinancing, interest expense, and cash generation important for financial health
Does Fortive disclose enough cash-flow evidence?
The supplied latest company figures do not disclose operating cash flow, capex, or free cash flow levels FMP shows Operating Cash Flow Growth: -3583% and Free Cash Flow Growth: -3794% for 2026-04-03, so investors should confirm conversion with future filings
Can buybacks pressure Fortive's balance sheet?
Buybacks can support per-share results, but they require funding discipline Fortive repurchased $16B in 2025 and ~$500M in Q1 2026, while also carrying Total Debt: $349B Investors should watch whether repurchases stay aligned with cash generation
What buffers Fortive against weaker demand?
Fortive's main buffer is recurring revenue from software, consumables, and services, which reached approximately 500% of total revenue This can reduce cyclicality, but healthcare capital equipment demand, tariffs, compensation costs, and interest rates remain important risks to monitor